Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies

医学 癌症 DNA甲基化 内科学 雷鸣 DNA DNA测序 计算生物学 癌症研究 遗传学 基因 生物 基因表达 物理 气象学
作者
Qiang Gao,Lin Ye,Binrong Li,G.Q. Wang,Liang Dong,Baochai Shen,Wenhui Lou,W.C. Wu,Dongliang Ge,Qian Zhu,Yu Xu,Jiayue Xu,Weihong Chang,Ping Lan,Ping‐Hong Zhou,Ming He,Guibin Qiao,S.K. Chuai,R.Y. Zang,Tianyu Shi
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:34 (5): 486-495 被引量:114
标识
DOI:10.1016/j.annonc.2023.02.010
摘要

Early detection of cancer offers the opportunity to identify candidates when curative treatments are achievable. The THUNDER study (THe UNintrusive Detection of EaRly-stage cancers, NCT04820868) aimed to evaluate the performance of enhanced linear-splinter amplification sequencing, a previously described cell-free DNA (cfDNA) methylation-based technology, in the early detection and localization of six types of cancers in the colorectum, esophagus, liver, lung, ovary, and pancreas.A customized panel of 161 984 CpG sites was constructed and validated by public and in-house (cancer: n = 249; non-cancer: n = 288) methylome data, respectively. The cfDNA samples from 1693 participants (cancer: n = 735; non-cancer: n = 958) were retrospectively collected to train and validate two multi-cancer detection blood test (MCDBT-1/2) models for different clinical scenarios. The models were validated on a prospective and independent cohort of age-matched 1010 participants (cancer: n = 505; non-cancer: n = 505). Simulation using the cancer incidence in China was applied to infer stage shift and survival benefits to demonstrate the potential utility of the models in the real world.MCDBT-1 yielded a sensitivity of 69.1% (64.8%-73.3%), a specificity of 98.9% (97.6%-99.7%), and tissue origin accuracy of 83.2% (78.7%-87.1%) in the independent validation set. For early-stage (I-III) patients, the sensitivity of MCDBT-1 was 59.8% (54.4%-65.0%). In the real-world simulation, MCDBT-1 achieved a sensitivity of 70.6% in detecting the six cancers, thus decreasing late-stage incidence by 38.7%-46.4%, and increasing 5-year survival rate by 33.1%-40.4%, respectively. In parallel, MCDBT-2 was generated at a slightly low specificity of 95.1% (92.8%-96.9%) but a higher sensitivity of 75.1% (71.9%-79.8%) than MCDBT-1 for populations at relatively high risk of cancers, and also had ideal performance.In this large-scale clinical validation study, MCDBT-1/2 models showed high sensitivity, specificity, and accuracy of predicted origin in detecting six types of cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
tong发布了新的文献求助10
刚刚
1秒前
VV发布了新的文献求助10
1秒前
酒酒完成签到,获得积分10
1秒前
Tia完成签到 ,获得积分10
1秒前
2秒前
Dawn完成签到,获得积分10
2秒前
科研通AI6.3的应助被清辉影采纳,获得10
2秒前
在水一方的应助被fortuna采纳,获得10
2秒前
3秒前
3秒前
文艺紫菜发布了新的文献求助10
4秒前
kinsley完成签到,获得积分10
4秒前
4秒前
Lucas的应助被punch采纳,获得10
4秒前
傢誠发布了新的文献求助10
4秒前
4秒前
快乐的鱼发布了新的文献求助10
5秒前
orixero的应助被zhz采纳,获得10
5秒前
5秒前
zz发布了新的文献求助10
6秒前
所所的应助被PEITON采纳,获得10
7秒前
jun完成签到,获得积分10
7秒前
qiaobbbbb发布了新的文献求助10
8秒前
章绝施发布了新的文献求助10
8秒前
cc发布了新的文献求助10
8秒前
66666发布了新的文献求助30
8秒前
8秒前
petrichor完成签到,获得积分10
9秒前
charles完成签到,获得积分10
10秒前
星辰大海的应助被123采纳,获得10
10秒前
10秒前
SciGPT的应助被平凡的一天采纳,获得10
10秒前
纯真的梦竹完成签到,获得积分10
11秒前
kinsley发布了新的文献求助10
12秒前
12秒前
Merkuro发布了新的文献求助10
12秒前
13秒前
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187592
求助须知:如何正确求助?哪些是违规求助? 9575705
关于积分的说明 21842471
捐赠科研通 7785407
什么是DOI,文献DOI怎么找? 3435057
关于科研通互助平台的介绍 2559461
邀请新用户注册赠送积分活动 2481952